American State Bank (Iowa)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,283
Closed -$181K 258
2023
Q4
$181K Sell
6,283
-13,427
-68% -$406K 0.12% 131
2023
Q3
$654K Buy
19,710
+1,672
+9% +$59.1K 0.47% 67
2023
Q2
$662K Sell
18,038
-202
-1% -$7.86K 0.46% 67
2023
Q1
$744K Buy
18,240
+244
+1% +$10.5K 0.54% 62
2022
Q4
$922K Sell
17,996
-885
-5% -$42.4K 0.71% 45
2022
Q3
$826K Hold
18,881
0.72% 43
2022
Q2
$990K Buy
18,881
+1,320
+8% +$67.3K 0.79% 36
2022
Q1
$909K Buy
17,561
+210
+1% +$10.9K 0.63% 49
2021
Q4
$1.02M Buy
17,351
+45
+0.3% +$2.23K 0.71% 41
2021
Q3
$744K Buy
17,306
+34
+0.2% +$1.51K 0.58% 58
2021
Q2
$676K Buy
17,272
+195
+1% +$7.58K 0.53% 63
2021
Q1
$619K Buy
17,077
+813
+5% +$28.9K 0.53% 64
2020
Q4
$599K Buy
+16,264
New +$597K 0.57% 61

Other funds holding PFE

American State Bank (Iowa)'s PFE Position: Q1 2024 in Review

American State Bank (Iowa) sold out of Pfizer (PFE) in Q1 2024, closing a stake of 6,283 shares — an estimated $181K sold.

American State Bank (Iowa) first reported a position in PFE in Q4 2020 and held it in 13 quarters. The position peaked at $1.02M in Q4 2021. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • American State Bank (Iowa) reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • American State Bank (Iowa) sold 6,283 Pfizer shares in Q1 2024, an estimated $181K.
  • American State Bank (Iowa) first reported a position in Pfizer in Q4 2020 and held it in 13 quarters.
  • American State Bank (Iowa)'s Pfizer position peaked at $1.02M in Q4 2021.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on American State Bank (Iowa)'s 13F filing for Q1 2024, filed 14 Apr 2026.